Public Health Agency of Canada
Symbol of the Government of Canada

Enterococcus Publications and Presentations

Publications

  1. Boyd, DA, T. Du, R. Hizon, B. Kaplen, T. Murphy, S. Tyler, S. Brown, F. Jamieson,  K. Weiss, MR. Mulvey, and the Canadian Nosocomial Infection Surveillance Program. 2006.  VanG-type vancomycin resistant Enterococcus faecalis isolated in Canada.  Antimicrobial Agents and Chemotherapy. 50:2217-2221. Link opens in new window / Ce lien ouvre une nouvelle fenêtre.
  1. Boyd, DA, M. A. Miller, and M. R. Mulvey. E. gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene. Antimicrobial Agents and Chemotherapy. 50:1067-70. Link opens in new window / Ce lien ouvre une nouvelle fenêtre.
  1. Boyd, D., P. Kibsey, D. Roscoe, M. R. Mulvey and the Canadian Nosocomial Infection Surveillance Program (CNISP). 2004.  Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance; characterization of the vanD5 operon.  Journal of Antimicrobial Chemotherapy. 54:680-683. Link opens in new window / Ce lien ouvre une nouvelle fenêtre.
  1. Boyd, D., T. Cabral, P. Van Caeseele, J. Wylie, and M.R. Mulvey. 2002.  Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada.  Antimicrobial Agents and Chemotherapy. 46:1977-1979. Link opens in new window / Ce lien ouvre une nouvelle fenêtre.
  1. Conly, J., M. Ofner-Agostini, S. Paton, L. Johnston, M. R. Mulvey, A. Kureishi, L. Nicholle, A. Matlow, The Canadian Epidimiology Committee, and The Canadian Nosocomial Infection Surveillance Program. 2001.  The emerging epidemiology of vancomycin-resistance in Canada: Results of the Canadian Nosocomial Infection Surveillance Program Passive Reporting Network 1994-1998.  The Canadian Journal of Infection Control. 16:71-80.
  1. Elsayed, S., N. Hamilton, D. Boyd, and M. R. Mulvey. 2001. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. Journal of Clinical Microbiology 39:2367-2368. Link opens in new window / Ce lien ouvre une nouvelle fenêtre.
  1. Campbell, J. L., P. Van Caeseele., S. Giercke, J. Wylie, S. Amin, M. Ofner-Agostini, D. Boyd, and M. R. Mulvey. 2001. Identification of the first Enterococcus faecalis harbouring vanE in Canada. Canadian Communicable Disease Reports. 27:101-104.
  1. Boyd, D A., J. Conly, H. Dedier, G. Peters, L. Robertson, E. Slater, and M. R. Mulvey. 2000. Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant Enterococus isolated in Canada.  Journal of Clinical Microbiology 38:2392-2394. Link opens in new window / Ce lien ouvre une nouvelle fenêtre.

Guidelines

Guidelines for the testing and reporting of antimicrobial susceptibilities of vancomycin resistant Enterococci. Canadian External Quality Assessment- Advisory Group on Antimicrobial Resistance. 1998.  ISBN 0-662-27498-9 Link opens in new window / Ce lien ouvre une nouvelle fenêtre.

Posters

  1. Boyd, D. A., R. Hizon, M. Miller, M. R. MulveyEnterococcus gallinarum N04-0414 Harbors VanD-Type Vancomycin Resistance and is Missing the ddl2 Gene 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).  Washington, DC, December 16 – 19, 2005. pdf
  1. Willey, B. M., N. Kreiswirth, P. Akhavan, U. Reischl, M. Mulvey, D. Boyd, T. Mazzulli, S. Eden, W. Lee, M. Skulnick and A. J. McGeer.  Feasibility of Direct-PCR Detection of Vancomycin-Resistant Enterococci VRE from Rectal Swabs.  Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Ottawa, ON, April 14 – 17, 2005.
  1. Johnston, B. L., M. Ofner-Agostini, D. Gravel, J. Conly, A. Simor, A. Matlow, J. Embil. M. Mulvey and S. Paton.  Vancomycin Resistant Enterococci (VRE) in Canadian Health Care Facilities:  5 Years of Prospective Surveillance (1998-2003).  Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Ottawa, ON, April 14 – 17, 2005.
  1. Johnston, L, M Ofner-Agostini, D Gravel, J Conly, A Simor, A Matlow, J Embil, M R. Mulvey, S Paton, Canadian Hospital Epidemiology Committee (CHEC), and Canadian Nosocomial Infection Surveillance Program (CNISP).  Vancomycin-Resistant Enterococci (VRE) in Canadian Health Care Facilities: 5 Years of Prospective Surveillance (1998-2003). IDSA (Sept. 30-Oct. 3, 2004), Boston MA.
  1. Mulvey, M. R., S. Tyler, Cote, T., K. Weiss, Identification of the first Enterococcus faecalis harbouring a vanG in Canada. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.
  1. Mulvey, M. R., L. Johnston, M. Ofner,., J. Conly, T. Du,., R. Hizon,., J. Embil,. A. Matlow, S. Paton, A. Simor,. three years of national surveillance for vanocmycin-resistant enterococci (VRE) in Canada: 1998-2001. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003. pdf
  1. Boyd, D., P. Van Caeseele,., T. Cabral, J. Wylie, S. Giercke,., R. Hizon, M. R. Mulvey, Molecular Characterization of the vanE Gene Region from a Vancomycin Resistant Enterococcus faecalis Isolated in Canada.  Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, Nov. 4-7, 2001.
  1. Dedier, H. J, I. Campbell, L. Burrows., M. R. Mulvey, D. Boyd, J. Conly. Identification of vanB-type vancomycin resistance (VR) in motile and non-motile Enterococcus gallinarum (EG). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Toronto, Ontario, Sept. 17-20, 2000.
  2. Johnston, L., S. Squires, J. Conly, A. Simor, A. Matlow, M. Ofner-Agostini, S. Paton, M. Mulvey, K. Green, CNISP.  Vancomycin resistant enterococci (VRE) in Canadian health care facilities: The first year of prospective surveillance.  2000 National Education Conference, Community and Hospital Infection Control Association-Canada, Toronto, Ont., May 29-31, 2000.
  1. Boyd, D, J. Conly, H. Dedier, L. Robertson, E. Slater, M. R. Mulvey. Molecular characterization of a vanD-type vancomycin resistant Enterococci (VRE) isolated in Canada. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, Sept. 26-29 1999.
  1. Boyd, D., J. Conly, H. Dedier, L. Robertson, E. Slater, M R. Mulvey. Molecular characterization of a vanD-type vancomycin resistant Enterococci (VRE) isolated in Canada.  67th Conjoint Meeting on Infectious Diseases, Edmonton, AB, Oct. 31-Nov.4 1999.
  1. Johnston, L., M. E. Ofner-Agostini, D. Holton, J. Conly, A. Simor, A. Matlow, S. Paton, M. R. Mulvey, the Canadian Hospital Epidemiology Committee. Laboratory and infection protocols for vancomycin-resistant enterococci (VRE): a survey of CHEC facilities.  Annual Conference, Community and Hospital Infection Control Association, Moncton, NB, May 31-June 2, 1999.
  1. Johnston, L, M. E. Offner-Agostini, D. Holton, J. Conly, A. Simor, A. Matlow, S. Paton, M. R. Mulvey, K. Green. Laboratory and infection protocols for vancomycin-resistant enterococci (VRE): A survey of CHEC facilities.  67th Conjoint Meeting on Infectious Diseases, Edmonton, Alta., Oct. 31-Nov. 4, 1999.  (Abstract P49)
  1. Conly, J., M. E. Ofner-Agostini, S. Paton., L. Johnston., A. Kureishi., L. Nicolle., A. Matlow., M. R. Mulvey., W. Johnson. The Canadian Hospital Epidemiology Committee, and Health Canada. The Emerging Epidemiology of Vancomycin Resistant Enterococci in Canada: Results of the Canadian Nosocomial Infection Surveillance Program (CNISP) Passive Reporting Network. Canadian Hospital Infection Control Association (CHICA), Kananaskis, Alberta; May 4-6, 1998.
  1. Dedier, H., M. R. Mulvey, and J. Conly. VanD-type vancomycin-resistant Enterococci (VRE) in Canada.  Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Toronto, Ontario, Nov. 8-12, 1998.
  1. Mulvey, M. R., R. Easy, W. Johnson. A rapid method to track Tn1546-like elements through a population of unrelated Enterococci.  Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Toronto, Ontario, Nov. 8-12, 1998.
  1. Mulvey, M., W. Johnson, M. Ofner, S. Paton, J. Conly, L. Nicolle, L. Johnston, A. Kureishi, A. Matlow, and the Canadian Hospital Epidemiology Committee (CHEC). Vancomycin Resistant Enterococci (VRE):  Interlaboratory Evaluation of the Canadian Nosocomial Infection Surveillance Program (CNISP) Point Prevalence Study. Interscience Conference on Antimicrobial Agents and Chemotherapy, 1997.
  1. Antonishyn, N., R. McDonald, W. Kuperus, M. R. Mulvey, S. Hudson, M. McKenzie, E. Chan and G. Horsman. Evaluation of AFLP for the DNA Fingerprinting of VRE Isolates. ASM Conference on Molecular Diagnostics and Therapeutics, 1997.
  1. Mulvey, M. R., P. Gibb, and W. Johnson. Horizontal Transmission of a Novel Tn1546-like Element between E. faecium and E. faecalis in a Single Patient.  International Conference on Emerging Infectious Diseases. 1997.